Vinge assists Nextmune Holding B.V., primarily owned by Fidelio Capital and Premune, in connection with the acquisition of the shares in Alergovet S.L. Alergovet is a leading company in Southern Europe focused on the diagnoses and treatment of atopic dermatitis for companion animals and horses, and offers high quality allergy tests and allergen-specific immunotherapy treatment for companion animals and horses.
Vinge’s team consists of partner Jonas Johansson together with, among others, associates Albert Wållgren, Linn Adelwald, Isabell Nielsen, Andréa Nicolin, Gustav Tengblad and Sofia Bergenstråhle.
